ORLANDO, Fla.
--(BUSINESS WIRE)--
LENSAR, Inc.
(NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on femtosecond laser surgical solutions for the treatment of cataracts, today announced that
Nick Curtis
, Chief Executive Officer will present at the 32nd Annual
Piper Sandler Virtual Healthcare Conference
. Mr. Curtis’ presentation will be available on-demand beginning at
10:00 a.m. Eastern Time
, and can be accessed through the Investors section of the Company's website at
https://ir.lensar.com
on
November 23, 2020
at
10 a.m. Eastern Time
. The webcast will be available for two weeks after the presentation has been posted.
Additionally,
Mr. Curtis
will be participating in one-on-one meetings with conference attendees on
December 1
and 2, 2020. Investors interested in meeting with
LENSAR
management may request a meeting through Piper Sandler, or by contacting
Lee Roth
at
lroth@burnsmc.com
.
About
LENSAR
LENSAR
is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision.
View source version on
businesswire.com
:
https://www.businesswire.com/news/home/20201123005637/en/
Thomas R. Staab
, II, CFO
ir.contact@lensar.com
Lee Roth
/
Cameron Radinovic
Burns McClellan
for
LENSAR
lroth@burnsmc.com
/
cradinovic@burnsmc.com
Source:
LENSAR, Inc.